|39.86|| +0.26 / +0.66%|
Anika Therapeutics, Inc. develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair. The company's products are based on hyaluronic acid, a natural chemical occurring, biocompatible polymer found throughout the body. It offers therapeutic products which include orthobiologics, dermal, ophthalmic, surgical and veterinary. The Orthobiologics products consist of joint health and orthopedic products which are used in a wide range of treatments from providing relief from the pain of osteoarthritis, to regenerating damaged tissue such as cartilage defects. The Dermal products consist of advanced wound care products and aesthetic dermal fillers which are used for the treatment of skin wounds ranging from burns to diabetic ulcers. The Ophthalmic business includes HA viscoelastic products used in ophthalmic surgery. The Surgical business consists of products used to prevent surgical adhesions and to treat ear, nose and throat disorders. The company was founded in 1992 and is headquartered in Bedford, MA.
|Charles H. Sherwood||President, Chief Executive Officer & Director|
|Francesco J. Luppino||Chief Operating Officer|
|Sylvia Cheung||Chief Financial Officer, Secretary & Treasurer|
|Edward S. Ahn||Chief Technology & Strategy Officer|
|Edward Gaj||Vice President-Business Development|